CD274 and colorectal carcinoma: Colorectal cancer (CRC) is the second leading cause of cancer‐related death worldwide,[10] and immunotherapy has been used for colorectal cancer with MSI‐H or dMMR.[11] Although patients with high PD‐L1 expression may benefit from immunotherapy,[12] the dynamic expression of PD‐L1 affected by treatments remains unclear.